Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
World J Gastroenterol. 2024 Nov 7;30(41):4496-4502. doi: 10.3748/wjg.v30.i41.4496.
In this manuscript, we comment on the article, which explores the anti-cancer effects of (CB) in tumor biology. We highlight its potential, particularly in hepatocellular carcinoma (HCC), where it inhibits the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways and induces apoptosis. CB contains compounds such as oleanolic acid and ursolic acid that target interleukin-6, mitogen-activated protein kinase 8, vascular endothelial growth factor, and caspase-3, offering anti-inflammatory and hepatoprotective benefits. The manuscript also discusses CB sativus (CBS), an artificial substitute, which has shown efficacy in reducing hepatic inflammation and oxidative stress in animal models. We emphasize the need for further research on the effects of CBS on the gut-liver axis and gut microbiota, and on targeting Wnt signaling and M2 tumor-associated macrophage as potential therapeutic strategies against HCC.
在这篇手稿中,我们对探讨 (CB)在肿瘤生物学中抗癌作用的文章进行了评论。我们强调了它的潜力,特别是在肝细胞癌(HCC)中,它可以抑制磷脂酰肌醇 3-激酶/蛋白激酶 B/雷帕霉素哺乳动物靶蛋白途径并诱导细胞凋亡。CB 含有齐墩果酸和熊果酸等化合物,可靶向白细胞介素-6、丝裂原活化蛋白激酶 8、血管内皮生长因子和半胱天冬酶-3,具有抗炎和保肝作用。该手稿还讨论了 CB sativus(CBS),一种人工替代品,已在动物模型中显示出减轻肝炎症和氧化应激的功效。我们强调需要进一步研究 CBS 对肠-肝轴和肠道微生物群的影响,以及针对 Wnt 信号和 M2 肿瘤相关巨噬细胞作为治疗 HCC 的潜在治疗策略。